Peddock Capital Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,080
Closed -$256K 168
2026
Q1
$256K Hold
4,080
0.06% 136
2025
Q4
$389K Sell
4,080
-102
-2% -$10K 0.08% 117
2025
Q3
$408K Hold
4,182
0.09% 119
2025
Q2
$449K Hold
4,182
0.1% 112
2025
Q1
$422K Buy
4,182
+38
+0.9% +$3.83K 0.11% 110
2024
Q4
$370K Hold
4,144
0.09% 120
2024
Q3
$347K Sell
4,144
-256
-6% -$20.2K 0.08% 126
2024
Q2
$339K Hold
4,400
0.09% 119
2024
Q1
$301K Hold
4,400
0.08% 132
2023
Q4
$254K Hold
4,400
0.08% 138
2023
Q3
$232K Hold
4,400
0.08% 132
2023
Q2
$238K Hold
4,400
0.08% 134
2023
Q1
$220K Hold
4,400
0.08% 142
2022
Q4
$204K Buy
+4,400
New +$191K 0.08% 134
2021
Q3
Sell
-4,596
Closed -$210K 142
2021
Q2
$210K Buy
+4,596
New +$193K 0.07% 141
2021
Q1
Sell
-4,596
Closed -$165K 168
2020
Q4
$165K Buy
+4,596
New +$166K 0.09% 119
2020
Q2
Sell
-6,581
Closed -$215K 103
2020
Q1
$215K Hold
6,581
0.16% 94
2019
Q4
$298K Hold
6,581
0.15% 89
2019
Q3
$268K Hold
6,581
0.15% 92
2019
Q2
$283K Hold
6,581
0.15% 88
2019
Q1
$253K Hold
6,581
0.14% 96
2018
Q4
$233K Sell
6,581
-669
-9% -$24.3K 0.14% 95
2018
Q3
$279K Hold
7,250
0.13% 97
2018
Q2
$237K Hold
7,250
0.12% 105
2018
Q1
$198K Hold
7,250
0.1% 114
2017
Q4
$180K Hold
7,250
0.09% 119
2017
Q3
$211K Hold
7,250
0.11% 111
2017
Q2
$201K Buy
+7,250
New +$192K 0.11% 113

Other funds holding BSX

Peddock Capital Advisors's BSX Position: Q2 2026 in Review

Peddock Capital Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,080 shares — an estimated $256K sold.

Peddock Capital Advisors first reported a position in BSX in Q2 2017 and held it in 28 quarters. The position peaked at $449K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Peddock Capital Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Peddock Capital Advisors sold 4,080 Boston Scientific shares in Q2 2026, an estimated $256K.
  • Peddock Capital Advisors first reported a position in Boston Scientific in Q2 2017 and held it in 28 quarters.
  • Peddock Capital Advisors's Boston Scientific position peaked at $449K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Peddock Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.